Vector-field statistics for the analysis of time varying clinical gait data

C. J. Donnelly, C. Alexander, T. C. Pataky, K. Stannage, S. Reid, Mark Robinson

Research output: Contribution to journalArticle

1 Citation (Scopus)
321 Downloads (Pure)

Abstract

Background In clinical settings, the time varying analysis of gait data relies heavily on the experience of the individual(s) assessing these biological signals. Though three dimensional kinematics are recognised as time varying waveforms (1D), exploratory statistical analysis of these data are commonly carried out with multiple discrete or 0D dependent variables. In the absence of an a priori 0D hypothesis, clinicians are at risk of making type I and II errors in their analyis of time varying gait signatures in the event statistics are used in concert with prefered subjective clinical assesment methods. The aim of this communication was to determine if vector field waveform statistics were capable of providing quantitative corroboration to practically significant differences in time varying gait signatures as determined by two clinically trained gait experts. Methods The case study was a left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin (BoNT-A) injection to their left gastrocnemius muscle. Findings When comparing subjective clinical gait assessments between two testers, they were in agreement with each other for 61% of the joint degrees of freedom and phases of motion analysed. For tester 1 and tester 2, they were in agreement with the vector-field analysis for 78% and 53% of the kinematic variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together and then compared to the vector-field analysis, they were in agreement for 83% of the time varying kinematic variables analysed. Interpretation These outcomes demonstrate that in principle, vector-field statistics corroborates with what a team of clinical gait experts would classify as practically meaningful pre- versus post time varying kinematic differences. The potential for vector-field statistics to be used as a useful clinical tool for the objective analysis of time varying clinical gait data is established. Future research is recommended to assess the usefulness of vector-field analyses during the clinical decision making process.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalClinical biomechanics (Bristol, Avon)
Volume41
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Gait
Biomechanical Phenomena
Statistical Data Interpretation
Botulinum Toxins
Cerebral Palsy
Skeletal Muscle
Injections

Cite this

@article{32795c9e31e04fdcbfb684ee93018fb3,
title = "Vector-field statistics for the analysis of time varying clinical gait data",
abstract = "Background In clinical settings, the time varying analysis of gait data relies heavily on the experience of the individual(s) assessing these biological signals. Though three dimensional kinematics are recognised as time varying waveforms (1D), exploratory statistical analysis of these data are commonly carried out with multiple discrete or 0D dependent variables. In the absence of an a priori 0D hypothesis, clinicians are at risk of making type I and II errors in their analyis of time varying gait signatures in the event statistics are used in concert with prefered subjective clinical assesment methods. The aim of this communication was to determine if vector field waveform statistics were capable of providing quantitative corroboration to practically significant differences in time varying gait signatures as determined by two clinically trained gait experts. Methods The case study was a left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin (BoNT-A) injection to their left gastrocnemius muscle. Findings When comparing subjective clinical gait assessments between two testers, they were in agreement with each other for 61{\%} of the joint degrees of freedom and phases of motion analysed. For tester 1 and tester 2, they were in agreement with the vector-field analysis for 78{\%} and 53{\%} of the kinematic variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together and then compared to the vector-field analysis, they were in agreement for 83{\%} of the time varying kinematic variables analysed. Interpretation These outcomes demonstrate that in principle, vector-field statistics corroborates with what a team of clinical gait experts would classify as practically meaningful pre- versus post time varying kinematic differences. The potential for vector-field statistics to be used as a useful clinical tool for the objective analysis of time varying clinical gait data is established. Future research is recommended to assess the usefulness of vector-field analyses during the clinical decision making process.",
keywords = "Biomechanics, Kinematics, Lower-limb, SPM, Statistical parametric mapping",
author = "Donnelly, {C. J.} and C. Alexander and Pataky, {T. C.} and K. Stannage and S. Reid and Mark Robinson",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.clinbiomech.2016.11.008",
language = "English",
volume = "41",
pages = "87--91",
journal = "Clinical biomechanics (Bristol, Avon)",
issn = "0268-0033",
publisher = "Elsevier",

}

Vector-field statistics for the analysis of time varying clinical gait data. / Donnelly, C. J.; Alexander, C.; Pataky, T. C.; Stannage, K.; Reid, S.; Robinson, Mark.

In: Clinical biomechanics (Bristol, Avon), Vol. 41, 01.01.2017, p. 87-91.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vector-field statistics for the analysis of time varying clinical gait data

AU - Donnelly, C. J.

AU - Alexander, C.

AU - Pataky, T. C.

AU - Stannage, K.

AU - Reid, S.

AU - Robinson, Mark

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background In clinical settings, the time varying analysis of gait data relies heavily on the experience of the individual(s) assessing these biological signals. Though three dimensional kinematics are recognised as time varying waveforms (1D), exploratory statistical analysis of these data are commonly carried out with multiple discrete or 0D dependent variables. In the absence of an a priori 0D hypothesis, clinicians are at risk of making type I and II errors in their analyis of time varying gait signatures in the event statistics are used in concert with prefered subjective clinical assesment methods. The aim of this communication was to determine if vector field waveform statistics were capable of providing quantitative corroboration to practically significant differences in time varying gait signatures as determined by two clinically trained gait experts. Methods The case study was a left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin (BoNT-A) injection to their left gastrocnemius muscle. Findings When comparing subjective clinical gait assessments between two testers, they were in agreement with each other for 61% of the joint degrees of freedom and phases of motion analysed. For tester 1 and tester 2, they were in agreement with the vector-field analysis for 78% and 53% of the kinematic variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together and then compared to the vector-field analysis, they were in agreement for 83% of the time varying kinematic variables analysed. Interpretation These outcomes demonstrate that in principle, vector-field statistics corroborates with what a team of clinical gait experts would classify as practically meaningful pre- versus post time varying kinematic differences. The potential for vector-field statistics to be used as a useful clinical tool for the objective analysis of time varying clinical gait data is established. Future research is recommended to assess the usefulness of vector-field analyses during the clinical decision making process.

AB - Background In clinical settings, the time varying analysis of gait data relies heavily on the experience of the individual(s) assessing these biological signals. Though three dimensional kinematics are recognised as time varying waveforms (1D), exploratory statistical analysis of these data are commonly carried out with multiple discrete or 0D dependent variables. In the absence of an a priori 0D hypothesis, clinicians are at risk of making type I and II errors in their analyis of time varying gait signatures in the event statistics are used in concert with prefered subjective clinical assesment methods. The aim of this communication was to determine if vector field waveform statistics were capable of providing quantitative corroboration to practically significant differences in time varying gait signatures as determined by two clinically trained gait experts. Methods The case study was a left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin (BoNT-A) injection to their left gastrocnemius muscle. Findings When comparing subjective clinical gait assessments between two testers, they were in agreement with each other for 61% of the joint degrees of freedom and phases of motion analysed. For tester 1 and tester 2, they were in agreement with the vector-field analysis for 78% and 53% of the kinematic variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together and then compared to the vector-field analysis, they were in agreement for 83% of the time varying kinematic variables analysed. Interpretation These outcomes demonstrate that in principle, vector-field statistics corroborates with what a team of clinical gait experts would classify as practically meaningful pre- versus post time varying kinematic differences. The potential for vector-field statistics to be used as a useful clinical tool for the objective analysis of time varying clinical gait data is established. Future research is recommended to assess the usefulness of vector-field analyses during the clinical decision making process.

KW - Biomechanics

KW - Kinematics

KW - Lower-limb

KW - SPM

KW - Statistical parametric mapping

UR - http://www.scopus.com/inward/record.url?scp=85006710389&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiomech.2016.11.008

DO - 10.1016/j.clinbiomech.2016.11.008

M3 - Article

VL - 41

SP - 87

EP - 91

JO - Clinical biomechanics (Bristol, Avon)

JF - Clinical biomechanics (Bristol, Avon)

SN - 0268-0033

ER -